HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.

AbstractBACKGROUND:
The proliferation of vascular endothelial cells and ultimately angiogenesis is inhibited by blocking integrin-mediated cell-matrix interaction. To asses the therapeutic potential of alpha(v)-integrin antagonists LM609 and cRGDfV in neovascularization of the anterior segment, their inhibitory effect on angiogenesis was studied in two rat models for corneal neovascularization.
METHODS:
Corneal neovascularization was induced in Wistar rats (n=51) either by silver nitrate burns or intrastromal implantation of polymer pellets containing 400 ng of fibroblast growth factor (bFGF). Animals were treated with subcutaneous injections of a cyclic alpha(v)-integrin antagonist (cRGDfV, 15 mg/kg body wt) or saline twice daily. Additional animals received intrastromal implants containing 400 ng bFGF together with either Lm609 (mAb, anti-alpha(v)beta(3)) or control antibody. Four days later, the animals were killed and the percentage of the surface area covered with vessels determined using digital image analysis.
RESULTS:
Systemic treatment with cRGDfV resulted in a significant reduction of corneal vessel growth in animals with bFGF-induced corneal vascularization. In corneas with silver nitrate burns, systemic cRGDfV treatment showed no significant reduction of vascularization compared with controls. Pellets containing bFGF and LM609 mAb induced significantly less neovascularization than pellets containing bFGF and control mAb.
CONCLUSION:
Our results suggest that in the rat cornea, alpha(v)beta(3) ligation does inhibit bFGF-induced neovascularization. A chemical burn of the cornea induces angiogenisis which is not inhibited by blocking alpha(v)-integrins. This suggests an angiogenic pathway independent of alpha(v)-integrins.
AuthorsO Klotz, J K Park, U Pleyer, C Hartmann, H Baatz
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (Graefes Arch Clin Exp Ophthalmol) Vol. 238 Issue 1 Pg. 88-93 (Jan 2000) ISSN: 0721-832X [Print] Germany
PMID10664059 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD
  • Integrin alphaV
  • Integrins
  • Peptides, Cyclic
  • cyclo(arginyl-glycyl-aspartyl-phenylalanyl-valyl)
  • Fibroblast Growth Factor 2
Topics
  • Animals
  • Antibodies, Monoclonal (therapeutic use)
  • Antigens, CD (drug effects)
  • Cornea (drug effects)
  • Corneal Neovascularization (chemically induced, pathology, prevention & control)
  • Female
  • Fibroblast Growth Factor 2 (toxicity)
  • Fluorescent Antibody Technique
  • Integrin alphaV
  • Integrins (antagonists & inhibitors, immunology)
  • Peptides, Cyclic (therapeutic use)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: